Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
RAPT
#1871
RAPT Therapeutics Inc
58.020
0
USD
+0.07%
Settore:
Salute
Base:
USD
Valuta di Profitto:
USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+0.07%
Variazione Mensile
+0.38%
Variazione di 6 mesi
+0.38%
Variazione Annuale
+0.38%
Chiusura Precedente
57.980
0
Open
58.020
0
Bid
58.020
0
Ask
58.023
0
Low
58.020
0
High
58.020
0
Volume
47
Mercati
Mercato Azionario Statunitense
Salute
RAPT
Open full chart
Financials
Overview
Estratto Conto
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
3.11 M
3.7 M
4.29 M
4.35 M
16.5 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.44
0.35
0.31
0.67
0.54
0.52
Return on equity %
0.51
0.37
0.34
0.79
0.68
0.6
Return on invested capital %
2 552.21
4 541.56
3 716.87
4 173.14
1 553.66
—
Gross margin %
100
100
100
—
—
—
Operating margin %
1 055.41
1 815.08
5 618.53
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 049.03
1 814.95
5 490.37
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.84
20.11
17.77
7.41
4.87
51.27
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.05
0.02
0.01
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
13.4
17.82
17.41
20.24
16.35
4.88
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
36.91
55.41
61.24
33.16
45.36
64.12
Net current asset value per share
38.27
56.36
62.12
33.76
46.17
65.36
Tangible book value per share
34.49
54.44
60.27
30.68
37.27
55.6
Working capital per share
34.38
53.56
58.63
29.2
36.68
54.57
Book value per share
34.49
54.44
60.27
30.68
37.27
55.6
Notizie
GSK completa l’acquisizione da 2,2 miliardi di dollari di RAPT Therapeutics
GSK completes $2.2 billion acquisition of RAPT Therapeutics
Le azioni di RAPT Therapeutics raggiungono il massimo a $57,98
RAPT Therapeutics stock hits 52-week high at $57.98
Le azioni di Rapt Therapeutics raggiungono il massimo di 52 settimane a 57,87 USD
Rapt Therapeutics stock hits 52-week high at 57.87 USD
Dal laboratorio al rally: Wells Fargo seleziona i migliori titoli biotech SMID-Cap per il 2026
Il titolo di Rapt Therapeutics raggiunge il massimo di 52 settimane a $57,71
Rapt Therapeutics stock reaches 52-week high at $57.71
GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout
Il titolo di Rapt Therapeutics raggiunge un massimo di 52 settimane a $57,62
Rapt Therapeutics stock hits 52-week high at $57.62